Movement Disorder News and Research

Latest Movement Disorder News and Research

Air pollution drives higher Parkinson’s risk and worsens symptoms in affected patients

Higher air pollution levels, particularly PM2.5 and NO2, significantly increase the risk of Parkinson's disease and worsen clinical outcomes like dyskinesia.

17 Sep 2024

AI-driven adaptive deep brain stimulation improves Parkinson’s symptoms

Researchers compare the safety and feasibility of an adaptive deep brain stimulation (aDBS) system to a conventional DBS system for Parkinson's disease.

22 Aug 2024

UCSF studies point the way toward continuous care for people with Parkinson's disease

Two new studies from UC San Francisco are pointing the way toward round-the-clock personalized care for people with Parkinson's disease through an implanted device that can treat movement problems during the day and insomnia at night.

19 Aug 2024

New insights into lipid-induced senescence in dopaminergic neurons

A new research perspective was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science), Volume 16, Issue 14 on July 19, 2024, entitled, "Lipid accumulation drives cellular senescence in dopaminergic neurons."

13 Aug 2024

Study suggests lower dementia risk for people with Parkinson's

There's some good news for people with Parkinson's disease: The risk of developing dementia may be lower than previously thought, or dementia may occur later in the course of the disease than previously reported, according to a study published in the August 7, 2024, online issue of Neurology, the medical journal of the American Academy of Neurology.

7 Aug 2024

Vanderbilt to introduce focused ultrasound for treating essential tremor and Parkinson's disease

The movement disorder neurology and neurosurgery team at Vanderbilt University Medical Center is set to add focused ultrasound treatment (FUS) as a new tool in the treatment of essential tremor and Parkinson's disease.

1 Aug 2024

Machine learning revolutionizes Parkinson's disease symptom tracking and progression prediction

Research develops an automated system using machine learning to quantify motor symptoms in Parkinson's disease and predict disease progression, offering new therapeutic insights.

28 Jul 2024

New preclinical model offers a unique platform for studying Parkinson's disease process

A new preclinical model offers a unique platform for studying the Parkinson's disease process and suggests a relatively easy method for detecting the disease in people, according to a new study led by Weill Cornell Medicine researchers.

23 Jul 2024

Blood test may aid early detection of Parkinson's and guide treatment strategies

To date Parkinson's disease (PD) is diagnosed clinically and rather late in the course of the disease. There is an urgent need to find an objective, quantifiable biomarker for the diagnosis of this highly prevalent movement disorder. Researchers have now found initial evidence that a blood test to detect the alpha-synuclein protein is a viable, less invasive option to diagnose PD. The study appears in the Journal of Parkinson's Disease, published by IOS Press, now part of Sage.

23 Jul 2024

AI model revolutionizes dementia diagnosis with high accuracy across multiple data sources

Researchers developed an AI model using multimodal data to accurately diagnose different types of dementia, enhancing early and personalized treatment.

8 Jul 2024

Study links agricultural pesticide exposure to increased genetic variants in Parkinson’s disease

Genetic characteristics that influence the risk of Parkinson's disease (PD) due to pesticide exposure.

1 May 2024

Monoclonal antibody Prasinezumab shows promise in slowing rapid Parkinson's progression

A recent study in Nature Medicine evaluated the efficacy of prasinezumab, a monoclonal antibody, in slowing the progression of motor symptoms in Parkinson’s disease patients with rapidly progressing forms, using phase II clinical trial data.

19 Apr 2024

Phase 2 trial reveals Lixisenatide may reduce motor disability in Parkinson’s patients

A trial of lixisenatide to assess its effects in early Parkinson’s disease.

18 Apr 2024

Emotional bodily sensations altered in Parkinson's disease

Emotions have a major impact on the way we act, and they regulate our hormones and many of the body's vital functions.

15 Apr 2024

Gut microbiome shows no clear link to cognitive impairments in Parkinson's disease

Study investigates the gut microbiome's role in Parkinson's disease patients with mild cognitive impairments, revealing no distinct microbiome signatures associated with MCI in PD compared to cognitively normal PD patients or controls.

8 Apr 2024

Study shows cellular, molecular overlaps in ALS and FTLD

On the surface, the movement disorder amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, and the cognitive disorder frontotemporal lobar degeneration (FTLD), which underlies frontotemporal dementia, manifest in very different ways. In addition, they are known to primarily affect very different regions of the brain.

22 Mar 2024

Skin biopsy test shows promise in diagnosing Parkinson's disease and synucleinopathies

In a paper published in the Journal of the American Medical Association (JAMA), neurologists at Beth Israel Deaconess Medical Center (BIDMC) showed that a simple skin biopsy test detects an abnormal form of alpha-synuclein, the pathological hallmark of Parkinson's disease and the subgroup of neurodegenerative disorders known as synucleinopathies, at high positivity rates.

20 Mar 2024

Movement Disorder News and Research

Latest Movement Disorder News and Research

Air pollution drives higher Parkinson’s risk and worsens symptoms in affected patients

AI-driven adaptive deep brain stimulation improves Parkinson’s symptoms

UCSF studies point the way toward continuous care for people with Parkinson's disease

New insights into lipid-induced senescence in dopaminergic neurons

Study suggests lower dementia risk for people with Parkinson's

Vanderbilt to introduce focused ultrasound for treating essential tremor and Parkinson's disease

Machine learning revolutionizes Parkinson's disease symptom tracking and progression prediction

New preclinical model offers a unique platform for studying Parkinson's disease process

Blood test may aid early detection of Parkinson's and guide treatment strategies

AI model revolutionizes dementia diagnosis with high accuracy across multiple data sources

Study links agricultural pesticide exposure to increased genetic variants in Parkinson’s disease

Monoclonal antibody Prasinezumab shows promise in slowing rapid Parkinson's progression

Phase 2 trial reveals Lixisenatide may reduce motor disability in Parkinson’s patients

Emotional bodily sensations altered in Parkinson's disease

Gut microbiome shows no clear link to cognitive impairments in Parkinson's disease

Study shows cellular, molecular overlaps in ALS and FTLD

Skin biopsy test shows promise in diagnosing Parkinson's disease and synucleinopathies

Innovative levodopa infusion pump trial shows promise for reducing Parkinson's symptoms

Essential tremor associated with increased risk of dementia

Diets impact Parkinson's motor symptoms, supplements show no benefit, study finds

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Movement Disorder News and Research

Latest Movement Disorder News and Research

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Newsletters you may be interested in